Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis.

Martin S SchulzSebastian WolfVera StruckNiklas ThomasGabriele HusmannStefan ZeuzemChristine KochJörg TrojanAndreas Anton SchnitzbauerWolf Otto BechsteinOliver Waidmann

Published in: Cancers (2022)

This retrospective study provides real-world evidence underscoring that anti-EGFR re-exposure strategies might benefit patients independently of the reason for prior discontinuation.

Keyphrases

small cell lung cancer
metastatic colorectal cancer
end stage renal disease
epidermal growth factor receptor
tyrosine kinase
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes